After the close, Monday, November 16, 2026
Monday's close
A broad decline on Monday: the S&P 500 (SPY) slid 1.94%, with 362 of 498 S&P names lower
The Nasdaq 100 (QQQ) sank 2.58%, the Dow (DIA) slid 1.45% and the Russell 2000 (IWM) slid 1.74%.
Also on this page
- Tuesday: 10 earnings reports, Walt Disney before the bell and NVIDIA after the close; Retail Sales Control Group and Retail Sales Ex Autos at 8:30 AM
- Tyson Foods Tops Lowered Q4 Estimates but Guides Fiscal 2027 Sales Down 3.5% to 5.5% on Beef Pressure
- Trip Group (TCOM) reported earnings; share price reaction pending
Briefs
- NY Empire State Manufacturing Index (Nov): 7.8 against 18 expected; MISS: below the estimate
- Market Mood moved from Anxiety to Fear
- Baidu (BIDU) beat the EPS estimate by 18.8%; share price reaction pending
- KE (BEKE) beat the EPS estimate by 40.0%; share price reaction pending
- OpenAI Signs Six-Year Deal With AMD-Backed TensorWave for 457 MW of MI455X Compute
- H World Group (HTHT) beat the EPS estimate by 16.3%; share price reaction pending
- Aramark (ARMK) missed the EPS estimate by 6.0%; share price reaction pending
- XPeng (XPEV) missed the EPS estimate by 26.5%; share price reaction pending
- U.S. Commerce Department Requires Licenses to Stop China Tapping Advanced AI Chips Through Overseas Data Centers
- AMD Completes World Labs Acquisition, Appoints Dr. Fei‑Fei Li as Chief Scientist
- Analysts Slash NVIDIA Price Targets, Mizuho to $220, UBS to $240, TD Cowen to $200
- White House Plans to Name Nvidia, Amazon, Microsoft, OpenAI and Anthropic AI 'National Champions', WSJ Reports
- Jensen Huang Weighs Return as Nvidia CEO, FT Reports, as Musk Warns Deals Could Be Lost
- US Treasury Secretary Calls for Dramatic Leadership Shakeup at NVIDIA
- FDA Rejects Summit Therapeutics' Ivonescimab in EGFR-Mutant Lung Cancer
This page is for research and education only and is not investment advice.
For the markets today, go to the SentiSense home page.